Trials / Conditions / Mucinous Adenocarcinoma of the Rectum

Mucinous Adenocarcinoma of the Rectum

22 registered clinical trials studyying Mucinous Adenocarcinoma of the Rectum.

Status	Trial	Sponsor	Phase
Terminated	Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors NCT03693846	Abramson Cancer Center at Penn Medicine	Phase 2
Terminated	Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Sprea NCT02110953	Fox Chase Cancer Center	Phase 1
Withdrawn	Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With St NCT02235324	University of Southern California	Phase 2
Completed	CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surg NCT02232152	Wake Forest University Health Sciences	Phase 1
Completed	Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer NCT02270606	Virginia Commonwealth University	Phase 1
Completed	Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Adv NCT02132858	Fox Chase Cancer Center	—
Terminated	Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemot NCT01934179	Fox Chase Cancer Center	—
Unknown	Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage NCT01871571	University of Southern California	Phase 2
Completed	Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer NCT01923337	University of California, Davis	Phase 1
Completed	Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab NCT01814501	John Hays	Phase 2
Completed	Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorect NCT01726296	Fox Chase Cancer Center	N/A
Completed	Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer NCT01652196	John Hays	Phase 2
Withdrawn	Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer NCT01403103	Case Comprehensive Cancer Center	EARLY_Phase 1
Completed	Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointest NCT01643499	University of Chicago	Phase 1
Terminated	Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal NCT01285102	Fox Chase Cancer Center	Phase 1
Terminated	Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed NCT01197664	Wake Forest University Health Sciences	Phase 1
Terminated	Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surg NCT00835679	National Cancer Institute (NCI)	EARLY_Phase 1
Completed	A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, an NCT00060411	National Cancer Institute (NCI)	Phase 1
Terminated	Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer NCT00052585	National Cancer Institute (NCI)	Phase 2
Completed	Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer NCT00005036	National Cancer Institute (NCI)	Phase 3
Completed	Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer NCT00003799	National Cancer Institute (NCI)	Phase 1
Terminated	Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer NCT00002796	National Cancer Institute (NCI)	Phase 1 / Phase 2